Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...

Skin condition flare-ups during the humid season are leading some individuals to avoid social events and celebrations.

While mild sunshine may tempt you to keep the same summer routine, dermatologists warn that winter requires a careful shift ...

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...

HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published in Nutrients.

Medical Channel Asia's ongoing eczema survey reveals how chronic itch drives withdrawal, emotional strain, and missed celebrations during a period ...

Equip health professionals with resources to diagnose and treat conditions across all skin tones. Make mental health support ...

A recent study revealed that iron deficiency without anemia is common among adults with moderate-to-severe atopic dermatitis ...

A new study published in the journal of Inflammopharmacology showed that in individuals with moderate-to-severe atopic ...